Plantain Spruce Cough


Uriel Pharmacy Inc.
Human Otc Drug
NDC 48951-8390
Plantain Spruce Cough is a human otc drug labeled by 'Uriel Pharmacy Inc.'. National Drug Code (NDC) number for Plantain Spruce Cough is 48951-8390. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Plantain Spruce Cough drug includes Atropa Belladonna - 5 [hp_X]/mL Cinchona Officinalis Bark - 5 [hp_X]/mL Drosera Rotundifolia - 4 [hp_X]/mL Helleborus Niger Root - 5 [hp_X]/mL Ipecac - 5 [hp_X]/mL Mephitis Mephitis Anal Gland Fluid - 7 [hp_X]/mL Petasites Hybridus Root - 1 [hp_X]/mL Picea Abies Whole - 1 [hp_X]/mL Plantago Lanceolata Whole - 1 [hp_X]/mL Protortonia Cacti - 5 [hp_X]/mL and more. The currest status of Plantain Spruce Cough drug is Active.

Drug Information:

Drug NDC: 48951-8390
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Plantain Spruce Cough
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Plantain Spruce Cough
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Uriel Pharmacy Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ATROPA BELLADONNA - 5 [hp_X]/mL
CINCHONA OFFICINALIS BARK - 5 [hp_X]/mL
DROSERA ROTUNDIFOLIA - 4 [hp_X]/mL
HELLEBORUS NIGER ROOT - 5 [hp_X]/mL
IPECAC - 5 [hp_X]/mL
MEPHITIS MEPHITIS ANAL GLAND FLUID - 7 [hp_X]/mL
PETASITES HYBRIDUS ROOT - 1 [hp_X]/mL
PICEA ABIES WHOLE - 1 [hp_X]/mL
PLANTAGO LANCEOLATA WHOLE - 1 [hp_X]/mL
PROTORTONIA CACTI - 5 [hp_X]/mL
SLOE - 1 [hp_X]/mL
VERATRUM ALBUM ROOT - 5 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 12 Jan, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Uriel Pharmacy Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:WQZ3G9PF0H
S003A158SB
QR44N9XPJQ
608DGJ6815
62I3C8233L
3BN57UN4US
97S2809V5R
D77PG8S4KK
TJ55Y9N2M4
LZB7TFX1LT
3MLB4858X7
QNS6W5US1Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
48951-8390-1125 mL in 1 BOTTLE, GLASS (48951-8390-1)12 Jan, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: temporary relief of cough and chest congestion.

Product Elements:

Plantain spruce cough plantain spruce cough sucrose vanilla atropa belladonna atropa belladonna cinchona officinalis bark cinchona officinalis bark citric acid monohydrate protortonia cacti protortonia cacti ipecac ipecac picea abies whole picea abies whole petasites hybridus root petasites hybridus root plantago lanceolata whole plantago lanceolata whole mephitis mephitis anal gland fluid mephitis mephitis anal gland fluid water cherry beet top helleborus niger root helleborus niger root veratrum album root veratrum album root sloe sloe drosera rotundifolia drosera rotundifolia

Indications and Usage:

Directions: for oral use only.

Warnings:

Warnings: claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. do not use if allergic to any ingredient. consult a doctor before use for serious conditions or if conditions worsen or persist. if pregnant or nursing, consult a doctor before use. do not use if safety seal is broken or missing. shake well before use. refrigerate after opening. best when used within 90 days of opening.

Dosage and Administration:

Take up to every hour as needed. ages 12 and older: 1 tablespoon. ages 4-11: 1 teaspoon. under age 4: consult a doctor.

Package Label Principal Display Panel:

Plantain spruce cough syrup

Further Questions:

Questions? call 866.642.2858 made with care by uriel, east troy, wi 53120 shopuriel.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.